Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation

Biochemical and Biophysical Research Communications

Volumn 298, Issue 5, 2002, Pages 693-698

  Kerokoski, Petri ^a   Suuronen, Tiina ^a   Salminen, Antero ^a,b   Soininen, Hilkka ^a,b   Pirttilä, Tuula ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

A23187; Alzheimer's disease; Calpain; Cell death; Glutamate; Ionomycin; MDL28170; NMDA

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; CALCIMYCIN; CALCIUM IONOPHORE; CALPAIN; CYCLIN DEPENDENT KINASE 5; ENZYME ACTIVATOR; GLUTAMIC ACID; IONOMYCIN; N METHYL DEXTRO ASPARTIC ACID; PROTEIN P25; PROTEIN P35; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM;

ANIMALS; CALCIMYCIN; CALPAIN; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DIPEPTIDES; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTAMIC ACID; IONOMYCIN; IONOPHORES; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 0036434290     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02543-3     Document Type: Article

References (27)

1. T. Hosoi, M. Uchiyama, E. Okumura, T. Saito, K. Ishiguro, T. Uchida, A. Okuyama, T. Kishimoto, S.-I. Hisanaga, Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract, J. Biochem. 117 (1995) 741-749.
2. H. Yamaguchi, K. Ishiguro, T. Uchida, A. Takashima, C.A. Lemere, K. Imahori, Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II, Acta Neuropathol. 92 (1996) 232-241.
3. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, L.-H. Tsai, Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration, Nature 402 (1999) 615-622.
4. E.T. Lund, R. McKenna, D.B. Evans, S.K. Sharma, W.R. Mathews, Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry, J. Neurochem. 76 (2001) 1221-1232.
5. M.-S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, L.-H. Tsai, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature 405 (2000) 360-364.
6. G.-I. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, S.-I. Hisanaga, Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25, J. Biol. Chem. 275 (2000) 17166-17172.
7. R. Nath, M. Davis, A.W. Probert, N.C. Kupina, X. Ren, G.P. Schielke, K.K.W. Wang, Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells, Biochem. Biophys. Res. Commun. 274 (2000) 16-21.
8. F. Grynspan, W.R. GriOn, A. Cataldo, S. Katayama, R.A. Nixon, Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease, Brain Res. 763 (1997) 145-158.
9. S. Taniguchi, Y. Fujita, S. Hayashi, A. Kakita, H. Takahashi, S. Murayama, T.C. Saido, S. Hisanaga, T. Iwatsubo, M. Hasegawa, Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains, FEBS Lett. 489 (2001) 46-50.
10. P. Kerokoski, T. Suuronen, A. Salminen, H. Soininen, T. Pirttilä, The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis, Biochem. Biophys. Res. Commun. 280 (2001) 998-1002.
11. T. Saito, K. Ishiguro, R. Onuki, Y. Nagai, T. Kishimoto, S. Hisanaga, Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons, Biochem. Biophys. Res. Commun. 252 (1998) 775-778.
12. T. Town, J. Zolton, R. Shaffner, B. Schnell, R. Crescentini, Y. Wu, J. Zeng, A. DelleDonne, D. Obregon, J. Tan, M. Mullan, p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro, J. Neurosci. Res. 69 (2002) 362-372.
13. Y. Zhu, L. Lin, S. Kim, D. Quaglino, R.A. Lockshin, Z. Zakeri, Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos, Cell Death Differ. 9 (2002) 421-430.
14. M.D. Nguyen, R.C. Lariviere, J.-P. Julien, Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions, Neuron 8 (2001) 135-147.
15. M.K. Ahlijanian, N.X. Barrezueta, R.D. Williams, A. Jakowski, K.P. Kowsz, S. McCarthy, T. Coskran, A. Carlo, P.A. Seymor, J.E. Burkhardt, R.B. Nelson, J.D. McNeish, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc. Natl. Acad. Sci. USA 97 (2000) 2910-2915.
16. F. Bian, R. Nath, G. Sobocinski, R.N. Booher, W.J. Lipinski, M.J. Callahan, A. Pack, K.K. Wang, L.C. Walker, Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice, J. Comp. Neurol. 446 (2002) 257-266.
17. A. Takashima, M. Murayama, K. Yasutake, H. Takahashi, M. Yokoyama, K. Ishiguro, Involvement of cyclin dependent kinase 5 activator p25 on tau phosphorylation in mouse brain, Neurosci. Lett. 306 (2001) 37-40.
18. B.H. Anderton, J.P. Brion, A.M. Couck, D.R. Davis, J.M. Gallo, D.P. Hanger, K. Ladhani, D.A. Latimer, C. Lewis, S. Lovestone, B. Marquardt, C.C.J. Miller, S.F.C. Mulot, C.H. Reynolds, T. Rupniak, C.J. Smith, S. Stabel, J. Woodgett, Modulation of PHF-like tau phosphorylation in cultured neurons and transfected cells, Neurobiol. Aging 16 (1995) 389-402.
19. D.R. Davis, J.P. Brion, A.M. Couck, J.M. Gallo, D.P. Hanger, K. Ladhani, C. Lewis, C.C. Miller, T. Rupniak, C. Smith, B.H. Anderton, The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures, Biochem. J. 309 (1995) 941-949.
20. L.M. Fleming, G.V.W. Johnson, Modulation of the phosphorylation state of tau in situ: The roles of calcium and cyclic AMP, Biochem. J. 309 (1995) 41-47.
21. E. Adamec, M. Mercken, M.L. Beermann, M. Didier, R.A. Nixon, Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau, Brain Res. 757 (1997) 93-101.
22. M.P. Mattson, Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons, Brain Res. 582 (1992) 107-118.
23. P. Sindou, M. Lesort, P. Couratier, C. Yardin, F. Esclaire, J. Hugon, Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex, Brain Res. 646 (1994) 124-128.
24. T. Saito, K. Ishiguro, T. Uchida, E. Miyamoto, T. Kishimoto, S. Hisanaga, In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons, FEBS Lett. 376 (1995) 238-242.
25. M.P. Mattson, M.G. Engle, B. Rychlik, Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons, Mol. Chem. Neuropathol. 15 (1991) 117-142.
26. A. Almeida, J.P. Bolaños, A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons, J. Neurochem. 77 (2001) 676-690.
27. S.G. Norman, G.V. Johnson, Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices, Neurochem. Res. 19 (1994) 1151-1158.